Marijuana earnings were down quarter , but recreational usage is still a bright spot for Canadian cannabis firm Aphria, CEO Irwin Simon told CNBC’s Jim Cramer Wednesday.Aphira earlier this afternoon posted its final quarterly results for its 2020 fiscal year, where Simon said recreational earnings were up 28%.”That is where the major opportunity is, it is recreational cannabis,” he explained in a “Mad Money” interview.Aphria, a significant manufacturer of medical and recreational marijuana, listed greater than $42 million, in U.S. dollars, in earnings of adult-use cannabis in its final quarter finished May 31. The business also stated that net earnings came in at roughly $114 million throughout the period, an 18% growth in the $96.43 million at the year-ago quarter. That defeat the $109 million that analysts were searching for, based on Factset estimates.Aphria’s annual declines, however, fell well below Wall Street’s estimates of a loss of 3 cents per share.Shares of Aphria, together with the remainder of the cannabis cohort, pumped together with the wider market from the March lows. The stock surged more than 181% from the lows in mid-March before Wednesday’s annual report, however, the talk price plummeted nearly 20% to $4.85 through Wednesday’s session because executives didn’t provide advice, Cramer noted.Despite the absence of advice, Simon stated that Aphria is keeping your eye on the developing attention to legalize marijuana in the USA, where marijuana was legalized in several dozen countries and stays entirely illegal in 11 other people. The plant is headquartered in some type in the rest of the countries.”Some of the vital matters … is legalization from the U.S.,” Simon stated.